Every price, name and term below was read from pallashealth.co on 1 September 2026 and is attributed to the company that published it. Where a fact comes from a government document instead, we say so and link it.
Disclosure: Pallas Health has an affiliate program and we are approved for it. Links labelled "(affiliate)" on this page may earn us a commission if you sign up. No company can pay to be included in, or ranked higher in, our comparisons, and we have never accepted payment to change what we write. Read our full affiliate disclosure.
The short version
Pallas Health prices sermorelin and NAD+ in twelve-week blocks and then converts those blocks to a monthly figure by dividing by three. Sermorelin and the NAD+ injection are "$597 every 12 weeks ($199/mo average)." The NAD+ nasal spray is "$567 every 12 weeks ($189/mo average)."
Twelve weeks is eighty-four days. A calendar month averages 30.4 days. So a twelve-week cycle recurs about 4.35 times a year, not four — and the true monthly cost is nearer $216 for sermorelin and the NAD+ injection, and $205 for the nasal spray. The arithmetic is a genuine difference of roughly $17 a month, or about $200 a year, on every one of these plans.
Against that, Pallas publishes more about how it operates than any other clinic in our eleven-company set. It names its physician with a verifiable NPI number, names six dispensing pharmacies with phone numbers, and cites the specific state telemedicine rules it is meeting. Those two facts sit side by side in this review because both are true.
What Pallas Health sells in the peptide category
Three peptide and longevity products, each a clinician-prescribed compounded preparation:
- Sermorelin injection — described as "a synthetic analog of growth hormone-releasing hormone (GHRH)," taken subcutaneously with clinician-personalised dosing.
- NAD+ injection — weekly.
- NAD+ nasal spray — daily.
The company also sells compounded GLP-1s and brand Wegovy, Zepbound, Ozempic and Mounjaro, plus skincare and women's hormone treatments. Those sit outside this page; our sister site covers the weight-loss side in its Pallas Health GLP-1 review.
Worth noting on the clinical framing: Pallas states plainly that sermorelin "is not growth hormone and is not an HGH replacement," and that it "works upstream." That is an accurate description, and it is more restrained than much of what is written about sermorelin online.
Prices as listed, 1 September 2026
| Product | First month | Then | Pallas calls this | Steady-state, per calendar month |
|---|---|---|---|---|
| Sermorelin injection | $89 | $597 every 12 weeks | $199/mo average | ~$216 |
| NAD+ injection | $89 | $597 every 12 weeks | $199/mo average | ~$216 |
| NAD+ nasal spray | $79 | $567 every 12 weeks | $189/mo average | ~$205 |
Each plan states that the price "includes provider care, ongoing check-ins, and care-team messaging — no separate membership fee," that it "auto-renews unless canceled," and that the price is "one price — never increases." A $60 visit deposit applies where a live video visit is required by state law.
Why twelve weeks is not three months
This is the whole of the disagreement, so here is the working in full.
A twelve-week cycle is 84 days. A year is 365 days. That is 365 ÷ 84 = 4.35 billing cycles a year, not four. At $597 a cycle, the annual cost is about $2,594, which divided across twelve calendar months is $216 a month. Pallas arrives at $199 by dividing $597 by three, which would only be right if twelve weeks were three calendar months. It is about 2.76 of them.
The same applies to the nasal spray: $567 × 4.35 = about $2,464 a year, or $205 a month rather than $189.
None of this is concealed — Pallas prints "$597 every 12 weeks" directly beside the averaged figure, which is more than several competitors do. The issue is that the averaged number is the one set in large type, and it is about 8 per cent below what the plan actually costs per calendar month. If you are comparing Pallas against a clinic that bills monthly, compare $216 against their monthly price, not $199.
Clinician and pharmacies, as the company names them
This is where Pallas is unusually strong, and it deserves saying clearly. Its clinical disclosures page — last updated 4 June 2026 — sets out the corporate structure, the clinical partner, the named medical leadership and the dispensing pharmacies, in plain language.
Pallas also explains why it publishes this: it cites Massachusetts Board of Registration in Medicine Policy 15-05, the Rhode Island Board of Medical Licensure and Discipline telemedicine guidelines, and the Vermont Board of Medical Practice telemedicine policy, all of which require telemedicine providers to make licensure and identifying information publicly available rather than only during a consultation. It states that every patient is given the name and license information of their specific treating clinician before a prescription is issued.
For context: of the eleven companies in our comparison, most name no clinician at all, and several name no pharmacy. Pallas names one physician with a verifiable federal identifier and six pharmacies with working contact details. Whatever you conclude about the pricing, that is the disclosure standard the rest of this category should be held to.
Refund and cancellation terms as written
The Terms state that you may cancel "at any time through your account settings or by contacting us," and that "cancellation takes effect at the end of your current billing period." Because the billing period is twelve weeks, cancelling the day after a renewal means the plan runs on for the remainder of that block.
On refunds, the product pages say: "If a clinician decides treatment isn't right for you, you're refunded in full." The Terms add that where a plan is not approved, or you cancel before a clinical decision, the $60 visit deposit is refunded in full — but that if your state requires a video visit and you neither attend nor reschedule it, "the deposit may be retained."
On price, the Terms reserve the right to change subscription prices "with at least 30 days' notice," taking effect at the start of a subsequent billing period. The product pages separately promise "one price — never increases." Those two statements are not identical, and the Terms are the document that governs.
What we could not verify
- Which of the six named pharmacies fills a given prescription. Pallas says this "depends on the medication, the patient's shipping state, and current capacity," which is honest but means you will not know in advance.
- Whether the $89 or $79 first month is followed immediately by a full $597 or $567 block, or whether the first block is prorated. The pages state the intro price and the recurring price but not the interval between them.
- How "one price — never increases" on the product pages is reconciled with the 30-day price-change clause in the Terms.
- Whether the $60 visit deposit is credited against the first month's cost or charged in addition to it.
Where these ingredients stand with FDA
Sermorelin is not an FDA-approved drug. The agency withdrew the approvals for both sermorelin new drug applications effective 18 June 2009; we set out that record in full in our account of the withdrawal. NAD+ sits within the compounding framework rather than the approval framework. Our legal status tracker records where each substance stands and what changed most recently.
Pallas labels both products "compounded in the USA" and states that 503A pharmacies are licensed and inspected by state boards of pharmacy while 503B outsourcing facilities are registered with and inspected by FDA under cGMP. That is an accurate description of the two regimes. The company also publishes an adverse-event route — FDA MedWatch on 1-800-FDA-1088 — alongside its own clinician contact, which is rare in this category and worth crediting.
Pallas additionally publishes a plain-English peptides guide distinguishing FDA-approved peptide drugs from lawfully compounded preparations and from "research use only" vendors. We disagree with none of its substance. It is unusual for a seller to publish a guide that draws that line honestly.
Who this suits
Pallas Health suits you if disclosure matters to you as much as price. You can look up the prescribing physician in a federal registry before you pay, you can phone the pharmacy that will fill your prescription, and you can read a compliance page that tells you which corporate entity is responsible for what. Very little else in this category offers that.
It suits you less if you want to pay monthly and know the number. The real figure is about $216 a month for sermorelin or NAD+ injection and about $205 for the nasal spray, and the twelve-week billing block means cancelling mid-cycle does not stop the current charge.
Affiliate link — we may be paid a commission if you sign up. It does not change what we report.
Contact them about
Whether the $60 deposit is credited against your first month, which pharmacy serves your state, when the first full twelve-week block is charged, and how the "never increases" promise squares with the 30-day price-change clause. These turn on your own circumstances and only the company can answer them. Ask Pallas Health before you pay.
How we sourced this
Sermorelin and NAD+ prices, plan terms and product descriptions were read from the sermorelin and NAD+ treatment pages on pallashealth.co on 1 September 2026. Corporate structure, clinical partner, named physician, NPI, pharmacy list and jurisdictions were read from the company’s clinical disclosures page the same day, which itself carries a "last updated 4 June 2026" date. Cancellation, refund and price-change terms were read from the company’s Terms the same day. The steady-state monthly figures are our own arithmetic on the company’s published prices, using 84 days per cycle and 365 days per year; we show the working above. The FDA position on sermorelin comes from the Federal Register, not from the company. We did not complete a purchase or enter the medical intake.
Compounded and non-approved medications are not FDA-approved. Nothing on this page is medical advice. Whether any of these products is appropriate for you is a decision for a licensed prescriber who knows your history.